Sarilumab
LTS11298
Phase 2 small_molecule terminated
Quick answer
Sarilumab for Ankylosing Spondylitis is a Phase 2 program (small_molecule) at Regeneron UK Limited with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Ankylosing Spondylitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated